Developmental Research Program

发展研究计划

• 批准号: 10468968
• 负责人: Marc Ladanyi
• 金额: $ 6.98万
• 依托单位: SLOAN-KETTERING INST CAN RESEARCH
• 依托单位国家: 美国
• 财政年份: 2018
• 资助国家: 美国
• 起止时间: 2018-09-01 至 2024-08-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10468968
• 关键词: Address; Advisory Committees; Animals; Award; Biology; Budgets; Cancer Etiology; Cause of Death; Clinical; Complement; Development; Diagnosis; Funding; Future; Generations; Goals; Growth; Human; Intervention; Investigator-Initiated Research; Knowledge; Lead; Leadership; Learning; Memorial Sloan-Kettering Cancer Center; Natural History; Pathogenesis; Patients; Philanthropic Fund; Process; Prognosis; Research; Research Personnel; Research Project Grants; Resources; Seeds; Soft tissue sarcoma; Talents; Testing; Translational Research; improved; innovation; preference; programs; recruit; sarcoma

Developmental Research Program ABSTRACT/DESCRIPTION The purpose of the Developmental Research Program of the MSKCC SPORE in Soft Tissue Sarcoma is to support innovative translational research projects in sarcoma. The translational research projects in this program aim to use knowledge of animal and human sarcoma biology to develop and test interventions related to improving diagnosis, prognosis, and treatment of patients with soft tissue sarcoma. This program will allow us to respond quickly to new opportunities in translational research and will help us recruit new scientific talent into our SPORE and, more broadly, into sarcoma-relevant research. The specific aims of the Developmental Research Program are: 1) to provide seed funding for innovative, investigator- initiated research in the biology, pathogenesis, progression, and natural history of sarcoma, 2) to fund research with exceptional potential to advance the translational research goals of the SPORE. We are budgeting $400,000 yearly for this program including $50,000 from the SPORE award itself and $350,000 in MSKCC institutional and philanthropic funds. The priority for funding will be those initiatives considered most creative and of the highest scientific quality. Preference will be given to projects that complement the long-term research goals of the SPORE and advance our translational research objectives. The executive committee can also solicit and fund experimental or clinical initiatives that address an urgent and specific need in the MSKCC SPORE in Soft Tissue Sarcoma program or a unique research opportunity. The internal scientific advisory committee will review applications to determine priorities for use of these funds and will annually select projects for funding. Projects may apply for a second year of funding through the same competitive process, and the projects that appear most promising will be considered for incorporation into the SPORE as Research Projects, either in current or future funding cycles.

发展研究计划